Integris Nazih Zuhdi Transplant Institute — Oklahoma City, Oklahoma

Integris Nazih Zuhdi Transplant Institute is a clinical research site located in Oklahoma City, Oklahoma, United States 73112.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Integris Nazih Zuhdi Transplant Institute has participated in 3 clinical trials.

Therapeutic areas: Delayed Graft Function, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Acute Antibody-Mediated Rejection (AMR).

Sponsors: Quark Pharmaceuticals, Biogen, Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

• University of Oklahoma Health Sciences Center Dept of OB/GYN
• University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC
• University of Oklahoma/ Health Science
• Bone and Joint Hospital at St. Anthony Research Department
• University Health Science Center/Cardio Section
• Stephenson Cancer Center - Oklahoma University
• St. Anthony Hospital - Conference Rooms
• Mercy Hospital Oklahoma City - Mercy Coletta Cancer Center - Oklahoma City
• University of Oklahoma Health Sciences Center - HPRC
• University of Oklahoma
• OU Medical Center Hospital
• University of Oklahoma - Department of Pharmacy Practice

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Integris Nazih Zuhdi Transplant Institute?

Integris Nazih Zuhdi Transplant Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Integris Nazih Zuhdi Transplant Institute conducted?

Integris Nazih Zuhdi Transplant Institute has 3 clinical trials on record. Their work covers Delayed Graft Function, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Acute Antibody-Mediated Rejection (AMR).

Is Integris Nazih Zuhdi Transplant Institute accredited by Crixeo Clinical Trials?

Integris Nazih Zuhdi Transplant Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Integris Nazih Zuhdi Transplant Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.